The dilution would be 50,000,000 shares and bring the TOTAL number of outstanding shares to 400,000,000. My guess is that the funds would be used to increase the sales force once it is approved by the FDA for IBS-C.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.